Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Journal of Innate Immunity

Guidelines for Authors
www.karger.com/jin_guidelines

Introduction
Submission
Conditions
Sections
Plagiarism Policy
Arrangement
References
Ethics
Conflict of Interest
Page Charges
Digital Object Identifier (DOI)
Supplementary Material
Self-Archiving/Green Open Access, Author's ChoiceTM,
   Funding Organizations (NIH etc.)

Color Illustrations
Video Files
Copy Editing
Proofs
E-pub First
Reprints


Introduction

The 'Journal of Innate Immunity' is a bimonthly published journal that aims to cover all aspects within the area of innate immunity, including evolutionary aspects, pathogen-host cell molecular interactions, host response and inflammation, complement and coagulation, microbial corruption of innate immunity, molecular genomics, development of vaccines and immune therapies. The journal features original papers (Research Articles, Clinical Investigations), Mini Reviews, Letters to the Editors, Rapid Communications and Short Communications.

Criteria for acceptance are quality, originality, and clarity. The 'Journal of Innate Immunity' will not consider papers that are either preliminary or purely descriptive. Reports on clinical cases are accepted only if they provide novel insight into unresolved problems of innate immunity.



Submission

Only original papers written in English are considered. Manuscripts (the preferred word-processing package is MS-Word) should be submitted online.

Angela Lorenz
Editorial Office 'Journal of Innate Immunity'
S. Karger AG
P.O. Box
CH-4009 Basel (Switzerland)
Tel. +41 61 306 1358
Fax +41 61 306 1434
jin@karger.com



Conditions

All manuscripts must be accompanied by a covering letter signed on behalf of all authors. Assurance should be given that the manuscript is not under simultaneous consideration by any other publication. Presentation of manuscripts should conform with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (see N Engl J Med 1997;336:309–315).

All manuscripts are subject to editorial review. Submission of an article for publication implies the transfer of the copyright from the author to the publisher upon acceptance. Accepted papers become the permanent property of 'Journal of Innate Immunity' and may not be reproduced by any means, in whole or in part, without the written consent of the publisher.

For legal reasons, we must receive your 'Submission Statement' with your original (hand-written) signature. Please download, print, sign and either fax or scan it to make it legally binding.

It is the authors' responsibility to obtain permission to reproduce illustrations, tables, etc. from other publications.



Sections

In addition to regular papers, every issue of the journal will have a special section with a thematic focus. Contributions to these special topic sections are very welcome and authors are asked to contact the Editors-in-Chief or the responsible guest editors before submitting a manuscript in order to avoid clashes with other pending papers.

All articles will undergo an indepth peer-review process.

Original Paper (Research Article / Clinical Investigation): Submitted manuscripts should be fully documented reports of original research. They must describe significant and original observations. The normal maximum length of an original paper is 10 printed pages, i.e. approximately 30 manuscript pages (font 12, double spacing) including title page, Abstract, Introduction, Materials and Methods, Results, Discussion, References, Figure Legends, Figures and Tables. The number of references should not exceed 40.

Review: The normal maximum length of a Review is limited to 5–7 printed pages, i.e. approximately 20 manuscript pages (font 12, double spacing), including 1–3 figures and/or tables. The number of references should not exceed 50. Potential authors are asked to contact the editors before submitting their papers in order to avoid clashes with other pending reviews.

Letter to the Editor: Letters to the Editor concerning articles published in 'Journal of Innate Immunity' may be submitted for publication. They should not be more than one printed page in length. If accepted, the authors of the articles concerned will be given the opportunity to reply.



Plagiarism Policy

Whether intentional or not, plagiarism is a serious violation. We define plagiarism as a case in which a paper reproduces another work with at least 25% similarity and without citation.
If evidence of plagiarism is found before/after acceptance or after publication of the paper, the author will be offered a chance for rebuttal. If the arguments are not found to be satisfactory, the manuscript will be retracted and the author sanctioned from publishing papers for a period to be determined by the responsible Editor(s).



Arrangement

Title page: The first page of each paper should indicate the title, the authors' names, the institute where the work was conducted, and a short title for use as running head.

Full address: The exact postal address of the corresponding author complete with postal code must be given at the bottom of the title page. Please also supply phone and fax numbers, as well as an e-mail address.

Key words: Please supply 3–10 key words in English that reflect the content of the paper.

Abstract: Each paper needs an abstract of up to 200 words describing background, methods, results and conclusions.

Footnotes: Footnotes should be avoided. When essential, they are numbered consecutively and typed at the foot of the appropriate page.

Tables and illustrations: Tables and illustrations (both numbered in Arabic numerals) should be prepared on separate pages. Tables require a heading and figures a legend, also prepared on a separate page. For technical reasons, figures with a screen background should not be submitted. When possible, group several illustrations on one block for reproduction (max. size 180 x 223 mm) or provide crop marks. Each illustration must be labelled with its number and the author's name. Electronically submitted b/w half-tone and color illustrations must have a final resolution of 300 dpi after scaling (final size), line drawings one of 800–1,200 dpi. Figure files should not be embedded in a document file but submitted separately (for detailed instructions, see Online Submission Instructions).



References

In the text identify references by Arabic numerals [in square brackets]. Material submitted for publication but not yet accepted should be noted as 'unpublished data' and not be included in the reference list. The list of references should include only those publications which are cited in the text. Do not alphabetize; number references in the order in which they are first mentioned in the text. The surnames of the authors followed by initials should be given. There should be no punctuation other than a comma to separate the authors. Preferably, please cite all authors. Abbreviate journal names according to the Index Medicus system. Also see International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals (www.icmje.org). Authors using EndNote® may choose the format setting for Intervirology for the correct format of References.

Examples

(a) Papers published in periodicals: Vilhelmsson M, Johansson C, Jacobsson-Ekman G, Crameri R, Zargari A, Scheynius A: The malassezia sympodialis allergen Mala s 11 induces human dendritic cell maturation, in contrast to its human homologue manganese superoxide dismutase. Int Arch Allergy Immunol 2007;143:155–162.

(b) Papers published only with DOI numbers: Theoharides TC, Boucher W, Spear K: Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol DOI: 10.1159/000063858.

(c) Monographs: Matthews DE, Farewell VT: Using and Understanding Medical Statistics, ed 4, revised. Basel, Karger, 2007.

(d) Edited books: Park BK, Sanderson JP, Naisbitt DJ: Drugs as haptens, antigens, and immunogens; in Pichler WJ (ed): Drug Hypersensitivity. Basel, Karger, 2007, pp 55–65.



Ethics

Published research must comply with the guidelines for human studies and animal welfare regulations. Authors should state that subjects have given their informed consent and that the study protocol has been approved by the institute's committee on human research and thus meets the standards of the Declaration of Helsinki in its revised version of 1975 and its amendments of 1983, 1989, and 1996 [JAMA 1997;277:925–926]. Information suitable to reveal the subject's identity is to be avoided. Further, they should also state that animal experiments conform to institutional standards. Copies of these guidelines and policy statements must be available for review by the editors if necessary.



Conflict of Interest

All forms of funding and support, including that from companies, and any potential competing financial interests should be acknowledged in the cover letter to the editor when applicable. The statement has to be listed at the end of the article.



Page Charges

There are no page charges for 5 or fewer printed pages, which is equal to approx. 14 manuscript pages including references, figures and tables. Each additional complete or partial printed page is charged to the authors at CHF 325.00.



Digital Object Identifier (DOI)

S. Karger Publishers supports DOIs as unique identifiers for articles. A DOI number will be printed on the title page of each article. DOIs can be useful in the future for identifying and citing articles published online without volume or issue information. More information can be found at www.doi.org



Supplementary Material

Multimedia files and other supplementary files, directly relevant but not essential to the conclusions of a paper, enhance the online version of a publication and increase its visibility on the web. These files will undergo editorial review. The Editors reserve the right to limit the scope and length of the supplementary material. Multimedia and supplementary material should meet production quality standards for publication without the need for any modification or editing. Files should not exceed 10 MB in size. Figures and tables need to have titles and legends, and all files should be supplied separately and labeled clearly. All supplementary material should be referred to in the main text. A DOI number will be assigned to supplementary material and it will be hosted online at https://karger.figshare.com under a CC BY license. Authors will be charged a processing fee of CHF 250.00 for supplementary material.



Self-Archiving/Green Open Access

Karger permits authors to archive their pre-prints (i.e. pre-peer review) or post-prints (i.e. accepted manuscript after peer review but before production) on their personal or their institution’s internal website. In addition, authors may post their accepted manuscripts in public Open Access repositories and scientific networks (e.g. ResearchGate or Mendeley) no earlier than 12 months following publication of the final version of their article. For all self-archiving, the posted manuscripts must:

  • Be used for noncommercial purposes only
  • Be linked to the final version on www.karger.com
  • Include the following statement:

‘This is the peer-reviewed but unedited manuscript version of the following article: [insert full citation, e.g. Cytogenet Genome Res 2014;142:227–238 (DOI: 10.1159/000361001)]. The final, published version is available at http://www.karger.com/?doi=[insert DOI number].’

It is the author’s responsibility to fulfill these requirements.

For papers published online first with a DOI number only, full citation details must be added as soon as the paper is published in its final version. This is important to ensure that citations can be credited to the article.

Manuscripts to be archived in PubMed Central due to funding requirements will be submitted by Karger on the author’s behalf [see Funding Organizations (NIH etc.)].

For self-archiving Author's ChoiceTM (Gold Open Access) articles, see Author's ChoiceTM.


Author's ChoiceTM

Karger’s Author's ChoiceTM service broadens the reach of your article and gives all users worldwide free and full access for reading, downloading and printing at www.karger.com. The option is available for a one-time fee of CHF 3,000.00 (EUR 3,000.00 / USD 3,530.00) , which is a permissible cost in grant allocation. More information can be found at www.karger.com/authors_choice.
The final, published version of the article may be posted at any time and in any repository or on other websites, in accordance with the relevant Creative Commons license. Reposted Open Access articles must:

  • Follow the terms of the relevant Creative Commons license
  • Be linked to the final version on www.karger.com
  • Include the following statement:

‘The final, published version of this article is available at http://www.karger.com/?doi=[insert DOI number].’

It is the author’s responsibility to fulfill these requirements.

For papers published online first with a DOI number only, full citation details must be added as soon as the paper is published in its final version. This is important to ensure that citations can be credited to the article.


Funding Organizations (NIH etc.)

The U.S. National Institutes of Health (NIH) Public Access Policy mandates that accepted, peer-reviewed manuscripts are archived in its digital database, PubMed Central (PMC), within 12 months of the official publication date. As a service to authors, Karger submits NIH-funded articles to PMC on behalf of the authors immediately upon publication. The NIH assigns a PMCID within approximately 1 month and the manuscript will appear in PMC after a 12-month embargo. For authors making their paper Open Access through Author's ChoiceTM, the embargo will be overridden, thereby accelerating the accessibility of the article. Karger also complies with other funders’ requirements (including Wellcome Trust and RCUK) for submission to PMC.
Authors should include information on their grant in the Acknowledgements section of their papers.




Color Illustrations

Online edition: Color illustrations are reproduced free of charge. In the print version, the illustrations are reproduced in black and white. Please avoid referring to the colors in the text and figure legends.
Print edition: Up to 6 color illustrations per page can be integrated within the text at CHF 960.00 per page.



Video Files

Video files for the 'Journal of Innate Immunity' enhance the online versions. The printed journal remains the archival version. Since it does not contain video files, the latter can only be supplements which improve the reader's understanding of the paper. In the printed version they should be replaced by a 'typical' figure. For further information, please refer to the Online Submission Instructions.



Copy Editing

All manuscripts accepted for publication by Karger are subject to copy editing. Changes introduced by the copy editor and/or questions will be marked in the manuscript so please be sure to check the proofs against the manuscript. The copy edited manuscript will be returned along with the proofs.



Proofs

Unless indicated otherwise, proofs are sent to the first-named author and should be returned with the least possible delay. Alterations made in proofs, other than the correction of printer's errors, are charged to the author. No page proofs are supplied.



E-pub First

All articles are published electronically ahead of print with a DOI number and are supplemented later with the definite reference of the printed version. The articles become available immediately after the authors' approval to print, with the added advantage of being citable much earlier than previously. Authors can influence the time of appearance by promptly returning the proofs.



Reprints

An order form and a price list are sent with the proofs. Orders submitted after the release of an article in print are subject to considerably higher prices.